160 related articles for article (PubMed ID: 36760244)
1. ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma.
Shu C; Liu L; Chen X; Xue J; Fei J; Wang J; Yang X; Peng Q; Yuan H
Ann Transl Med; 2023 Jan; 11(1):10. PubMed ID: 36760244
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets.
Wu M; Shang X; Sun Y; Wu J; Liu G
PeerJ; 2020; 8():e8961. PubMed ID: 32419983
[TBL] [Abstract][Full Text] [Related]
3. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
4. Noncoding RNAs-based high KIF26B expression correlates with poor prognosis and tumor immune infiltration in colon cancer.
Liu Z; Zhou X; Chen B; Wu Z; Zhang C; Gu C; Li J; Yang X
Cell Cycle; 2023; 22(14-16):1726-1742. PubMed ID: 37436127
[TBL] [Abstract][Full Text] [Related]
5. Noval ceRNA axis-mediated high expression of
Wang XQ; Li LL; Lou P; Zhang Q; Wang Y
Transl Cancer Res; 2023 Dec; 12(12):3486-3502. PubMed ID: 38193002
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA XIST/miR-29b-3p/COL3A1 axis regulates central carbon metabolism in head and neck squamous cell carcinoma and is associated with poor tumor prognosis.
Li Q; Miao J; Shi N; Lin C; Hu X; Shen Y
Ann Transl Med; 2023 Feb; 11(4):165. PubMed ID: 36923098
[TBL] [Abstract][Full Text] [Related]
7. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
[TBL] [Abstract][Full Text] [Related]
8. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new pseudogenes/lncRNAs-hsa-miR-26b-5p-COL12A1 competing endogenous RNA network associated with prognosis of pancreatic cancer using bioinformatics analysis.
Jing S; Tian J; Zhang Y; Chen X; Zheng S
Aging (Albany NY); 2020 Oct; 12(19):19107-19128. PubMed ID: 33027767
[TBL] [Abstract][Full Text] [Related]
10.
Xu T; Xu S; Yao Y; Chen X; Zhang Q; Zhao X; Wang X; Zhu J; Liu N; Zhang J; Lin Y; Zou J
J Thorac Dis; 2022 Feb; 14(2):515-535. PubMed ID: 35280459
[TBL] [Abstract][Full Text] [Related]
11. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma.
Gong M; Feng S; Zhou D; Luo J; Lin T; Qiu S; Yuan R; Dong W
Eur J Med Res; 2023 Oct; 28(1):440. PubMed ID: 37848987
[TBL] [Abstract][Full Text] [Related]
13. Potential upstream lncRNA-miRNA-mRNA regulatory network of the ferroptosis-related gene
Xu F; Ji S; Yang L; Li Y; Shen P
Transl Androl Urol; 2023 Jan; 12(1):33-57. PubMed ID: 36760866
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma.
Chalbatani GM; Momeni SA; Mohammadi Hadloo MH; Karimi Z; Hadizadeh M; Jalali SA; Miri SR; Memari F; Hamblin MR
Comput Biol Med; 2022 Feb; 141():105043. PubMed ID: 34839901
[TBL] [Abstract][Full Text] [Related]
15. nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract][Full Text] [Related]
16. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
18.
Meng L; He X; Hong Q; Qiao B; Zhang X; Wu B; Zhang X; Wei Y; Li J; Ye Z; Xiao Y
Front Oncol; 2021; 11():618187. PubMed ID: 33692955
[TBL] [Abstract][Full Text] [Related]
19. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer.
Wu Z; Wang Y; Li J; Wang H; Tuo X; Zheng J
Front Genet; 2022; 13():864578. PubMed ID: 35664337
[No Abstract] [Full Text] [Related]
20. Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction.
Lyu X; Qiang Y; Zhang B; Xu W; Cui Y; Ma L
Front Oncol; 2022; 12():1016542. PubMed ID: 36408130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
